Pulmonary hypertension in idiopathic pulmonary fibrosis.
about
Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management StrategiesCardiac manifestations of idiopathic pulmonary fibrosisSildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.Evaluation of recently validated non- invasive formula using basic lung functions as new screening tool for pulmonary hypertension in idiopathic pulmonary fibrosis patientsVariable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia.Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.Significance of pulmonary arterial pressure as a prognostic indicator in lung-dominant connective tissue disease.Pulmonary heart disease: The heart-lung interaction and its impact on patient phenotypes.Herpes virus infection is associated with vascular remodeling and pulmonary hypertension in idiopathic pulmonary fibrosisPulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis.Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis.An official American Thoracic Society Statement: pulmonary hypertension phenotypesPrognostic value of cardiovascular magnetic resonance derived right ventricular function in patients with interstitial lung disease.Combined Pulmonary Fibrosis and Emphysema Syndrome: A New Phenotype within the Spectrum of Smoking-Related Interstitial Lung DiseaseMean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.Update in Pulmonary Vascular Diseases 2014.Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosis.Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodynamics in idiopathic pulmonary fibrosis.Determinants of 6-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluation.Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary FibrosisAltered Hypoxic-Adenosine Axis and Metabolism in Group III Pulmonary HypertensionPulmonary hypertension in Saudi Arabia: A single center experience.Targeting NOX enzymes in pulmonary fibrosisDiminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosis.Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis.VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats.The Role of Cardiopulmonary Exercise Test in IPF Prognosis.Assessment of perfusion pattern and extent of perfusion defect on dual-energy CT angiography: correlations between the causes of pulmonary hypertension and vascular parameters.Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.Vascular remodelling in the pathogenesis of idiopathic pulmonary fibrosis.Recent evidence for pharmacological treatment of idiopathic pulmonary fibrosis.Expression profile of mitochondrial voltage-dependent anion channel-1 (VDAC1) influenced genes is associated with pulmonary hypertension.Inhibition of Hyaluronan Synthesis Attenuates Pulmonary Hypertension Associated with Lung Fibrosis.Pulmonary hypertension associated with lung diseases and hypoxemia.The diagnosis of idiopathic pulmonary fibrosis and its complications.Pulmonary hypertension as a risk factor of mortality after lung transplantation.Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.
P2860
Q26738405-C1964E3D-19F0-4D75-B926-600737ACB1FAQ26748176-C42B2A20-6AAB-4A0C-B6B8-07C50E70FCB4Q30412726-2DBA91A8-A980-470D-A9D1-9C596C4A811AQ33568625-D591EA2A-950D-4ACC-83EF-500746767D6FQ33636412-02E3D055-724F-4F59-90FB-E37284943E1AQ33843136-5F07D7DA-8696-45E0-90B0-83ADE6358D69Q34277188-973C0D45-C928-411B-888A-3696E7D3AE31Q34343972-85EA8CCD-306C-4DD4-82CE-F8261F20A05FQ34611385-C3D2824A-CF6E-4CEE-BE8E-9F67AF57B601Q34752135-BFF07212-D501-48C2-914E-F96A17EC94B1Q34764561-9E867FCC-AADC-458D-B364-51D47EF4C48DQ34919733-16D24F25-12D0-4DA8-9A3A-A6D4771F696CQ35068177-4D5F4556-C094-4369-96D4-6CBEC44131F7Q35789122-F0AD8E15-1795-410C-9831-5EEC446F89C0Q35993982-0D6D855B-9D7C-4DEB-BBDD-00CABF9CB2C5Q36128639-0CBCBD5E-58D9-4541-A844-B175D2A4E865Q36352101-8E8125EE-A1AA-4AF1-B9DF-442172940BACQ36390205-B6A03AA9-A229-4F4F-A332-ECF9D9267272Q36734220-09C90FF6-E5FE-40CD-84A8-1CF7FBE103FCQ36739149-C35EAE56-5FE1-4857-9531-3861066DE95DQ36765972-46ACBD02-D74C-437F-8253-92245E1C7872Q36886438-7E41BD38-0542-406D-96FD-1B31B31BFE1DQ37008372-F3EA4462-26CA-473C-9D40-D6D409D060B7Q37070077-5E0DFD9A-42A1-4AEE-9F1C-303458805085Q37073823-CD9ABD50-0FA0-42D9-8444-9AAB94D55A89Q37126872-4048A7C7-AB31-4779-AFA4-1DC099133485Q37170742-8A831DCD-DA49-4E35-B592-61A01AA11638Q37323225-04D0C523-5777-4B24-A6A9-63A89CC46FF0Q37640167-3B6D529D-68CF-4AEC-94B8-86AEA8454BE3Q37668859-DB4AD71A-7454-47E5-84F7-F56044239F4AQ37698249-118FE256-9C4B-44A3-A3D0-BB877A517F3DQ37890199-8F37F53E-58EF-49F7-A995-4BE91EBDFEA6Q38181043-93000D9A-1FA0-441E-B5EA-577D1D09570FQ38247265-EEB1F480-A93B-4BFC-ACDA-8E20FC75FD6FQ38434085-B44624C5-AB20-464A-A2A1-4FE3AF68E208Q38688645-95951987-1768-4106-8956-1EA42E5A57EAQ38810145-2F3F73D4-F7AC-471F-ABC9-3A58341A0A8AQ40024041-50D17C9F-CA82-4486-94E1-C7071FC1A896Q40967652-3E800A85-E36A-4C58-A6F6-30DC205F0C5AQ42375474-A0FD565C-D544-4684-B631-E1014DA5A77B
P2860
Pulmonary hypertension in idiopathic pulmonary fibrosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pulmonary hypertension in idiopathic pulmonary fibrosis.
@en
type
label
Pulmonary hypertension in idiopathic pulmonary fibrosis.
@en
prefLabel
Pulmonary hypertension in idiopathic pulmonary fibrosis.
@en
P2093
P356
P1433
P1476
Pulmonary hypertension in idiopathic pulmonary fibrosis
@en
P2093
Alain C Borczuk
Nina M Patel
Steven M Kawut
P304
P356
10.1378/CHEST.06-3087
P407
P577
2007-09-01T00:00:00Z